These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 1573143

  • 1. An analysis of FDA passive surveillance reports of seizures associated with consumption of aspartame.
    Tollefson L, Barnard RJ.
    J Am Diet Assoc; 1992 May; 92(5):598-601. PubMed ID: 1573143
    [Abstract] [Full Text] [Related]

  • 2. Multiple chemical sensitivity: controlled scientific studies as proof of causation.
    Tollefson L.
    Regul Toxicol Pharmacol; 1993 Aug; 18(1):32-43. PubMed ID: 8234917
    [Abstract] [Full Text] [Related]

  • 3. Aspartame intolerance.
    Garriga MM, Metcalfe DD.
    Ann Allergy; 1988 Dec; 61(6 Pt 2):63-9. PubMed ID: 3061324
    [Abstract] [Full Text] [Related]

  • 4. Aspartame: scientific evaluation in the postmarketing period.
    Butchko HH, Stargel WW.
    Regul Toxicol Pharmacol; 2001 Dec; 34(3):221-33. PubMed ID: 11754527
    [Abstract] [Full Text] [Related]

  • 5. Postmarketing surveillance of food additives.
    Butchko HH, Tschanz C, Kotsonis FN.
    Regul Toxicol Pharmacol; 1994 Aug; 20(1 Pt 1):105-18. PubMed ID: 7838988
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases.
    Coté TR, Mohan AK, Polder JA, Walton MK, Braun MM.
    J Am Acad Dermatol; 2005 Sep; 53(3):407-15. PubMed ID: 16112345
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Food and Drug Administration surveillance of the role of foreign objects in foodborne injuries.
    Hyman FN, Klontz KC, Tollefson L.
    Public Health Rep; 1993 Sep; 108(1):54-9. PubMed ID: 8434098
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004).
    DuMouchel W, Fram D, Yang X, Mahmoud RA, Grogg AL, Engelhart L, Ramaswamy K.
    Ann Clin Psychiatry; 2008 Sep; 20(1):21-31. PubMed ID: 18297583
    [Abstract] [Full Text] [Related]

  • 13. Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions.
    Wysowski DK, Corken A, Gallo-Torres H, Talarico L, Rodriguez EM.
    Am J Gastroenterol; 2001 Jun; 96(6):1698-703. PubMed ID: 11419817
    [Abstract] [Full Text] [Related]

  • 14. Form for reporting serious adverse events and product problems with human drug and biological products and devices; availability--FDA. Notice.
    Fed Regist; 1993 Jun 03; 58(105):31596-614. PubMed ID: 10171452
    [Abstract] [Full Text] [Related]

  • 15. Postmarketing studies for approved human drug and licensed biological products; status reports. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Oct 30; 65(210):64607-19. PubMed ID: 11503687
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Medical device vigilance at FDA.
    Gross TP, Kessler LG.
    Stud Health Technol Inform; 1996 Oct 30; 28():17-24. PubMed ID: 10164091
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.